Dow Down 0.22% Nasdaq Up 0.14%

Enzon Pharmaceuticals Inc. (ENZN)

-NasdaqCM
1.28 Up 0.01(0.79%) Aug 22, 4:00PM EDT
|After Hours : 1.28 0.00 (0.00%) Aug 22, 4:00PM EDT
Prev Close:1.27
Open:1.29
Bid:1.24 x 3400
Ask:1.32 x 10000
1y Target Est:14.00
Beta:1.28
Next Earnings Date:N/A
Day's Range:1.27 - 1.29
52wk Range:0.78 - 1.91
Volume:405,518
Avg Vol (3m):549,430
Market Cap:56.48M
P/E (ttm):2.43
EPS (ttm):0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ENZN

Comparison

Symbol% ChgMkt Cap
ENZNUp 0.79%56.48M
ISISUp 0.47%4.04B
NKTRUp 0.90%1.71B
PFEUp 0.35%183.38B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.70
Ex-Dividend Date:24-Dec-13

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Enzon Pharmaceuticals, Inc. is engaged in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for Melanoma; Macugen for neovascular age-related macular degeneration; CIMZIA for Crohn’s disea... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback